ENNUMO Trademark

Trademark Overview

On Thursday, August 11, 2022, a trademark application was filed for ENNUMO with the United States Patent and Trademark Office. The USPTO has given the ENNUMO trademark a serial number of 97544809. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, September 19, 2024. This trademark is owned by Accord BioPharma, Inc.. The ENNUMO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for stimulating white blood cell production
ennumo

General Information

Serial Number97544809
Word MarkENNUMO
Filing DateThursday, August 11, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, September 19, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 24, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 31, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameAccord BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRaleigh, NC 27617
Party NameAccord BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDurham, NC 27703

Trademark Events

Event DateEvent Description
Saturday, December 17, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, August 15, 2022NEW APPLICATION ENTERED
Wednesday, August 31, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, December 17, 2022ASSIGNED TO EXAMINER
Wednesday, January 4, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 24, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 24, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 21, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, March 15, 2024SOU TEAS EXTENSION RECEIVED
Friday, March 15, 2024SOU EXTENSION 2 FILED
Friday, March 15, 2024SOU EXTENSION 2 GRANTED
Thursday, May 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 22, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 22, 2023SOU EXTENSION 1 FILED
Tuesday, August 22, 2023SOU EXTENSION 1 GRANTED
Thursday, August 24, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, March 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, September 19, 2024SOU TEAS EXTENSION RECEIVED
Thursday, September 19, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, September 19, 2024SOU EXTENSION 3 FILED
Thursday, September 19, 2024SOU EXTENSION 3 GRANTED
Thursday, May 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, May 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, May 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

Related Keywords

ennumo cell production blood white preparations stimulating pharmaceutical